STAT Summit
Hear industry analysis from the top executives, researchers, policymakers, and patient advocates who have spoken at past STAT Summits. See our list of stories from past summits below.
Most Read
Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug
This invite-only club is grooming new biotech CEOs — and helping make them less lonely, too
Gilead CEO Daniel O’Day says company is in an ‘acquisitive mode’
As FDA toils over how to regulate CBD, frustration builds on all sides
Gene therapy pioneer says the field is behind — and that delivery technology is ‘embarrassing’
A bold prediction: Machine learning will yield new drug candidates within three years
‘The industry has earned it’: Three CEOs own up to biopharma’s bad reputation
All Coverage
advertisement
